LuMind IDSC issues statement following FDA full approval of Leqembi™ to treat early-stage Alzheimer’s disease July 7, 2023 In a groundbreaking decision that signals new hope for people with Alzheimer’s […]
Last week the FDA announced a full approval of a new drug called Leqembi to treat Alzheimer’s Disease. The approval is a milestone in helping to address the disease, however, […]
by guest contributor, Crystal Lotterberry, co-founder of the Black Down Syndrome Association About the Black Down Syndrome Association The Black Down Syndrome Association is helping to create a more inclusive […]
This systematic literature review focuses on co-teaching and inclusion in mathematics education. Co-teaching, in which two or more teachers share responsibility for students’ mathematical learning, can cater to students in […]
The guidebook linked below was published by the National Down Syndrome Society “to help empower families and caregivers with knowledge about the connection between Down syndrome and Alzheimer’s disease, suggestions […]
This review focuses on the diagnosis, prevalence, and management of cardiovascular disease encountered in people with Down syndrome and summarizes available evidence in 10 key areas relating to Down syndrome […]
